Stockreport

Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update [Yahoo! Finance]

Belite Bio, Inc - American Depositary Shares  (BLTE) 
PDF disease type 1 (STGD1), the Company is on track to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in Q2 2026 Completed enrollment i [Read more]